Decrease in alpha-fetoprotein levels predicts reduced incidence of hepatocellular carcinoma in patients with hepatitis C virus infection receiving interferon therapy: a single center study

Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection

(2010) Yasuhiro Asahina et al.   HEPATOLOGY

Hepatic steatosis in chronic hepatitis C is a significant risk factor for developing hepatocellular carcinoma independent of age, sex, obesity, fibrosis stage and response to interferon therapy

(2010) Masayuki Kurosaki et al.   HEPATOLOGY RESEARCH

Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus

(2010) Masakuni Tateyama et al.   JOURNAL OF GASTROENTEROLOGY

Effect of interferon α-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis

(2009) Mika Kurokawa et al.   HEPATOLOGY RESEARCH

Incidence of hepatocellular carcinoma in hepatitis C carriers with normal alanine aminotransferase levels

(2009) Takashi Kumada et al.   JOURNAL OF HEPATOLOGY

Serum Alpha-Fetoprotein Levels During and After Interferon Therapy and the Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C

(2008) Yasushi Tamura et al.   DIGESTIVE DISEASES AND SCIENCES

Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease

(2008) Anna S. Lok et al.   GASTROENTEROLOGY

Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon

(2008) Adrian M. Di Bisceglie et al.   NEW ENGLAND JOURNAL OF MEDICINE